PAPSS2 and cancer: Increased PAPSS2 expression was linked to increased drug sensitivity of cancer cells to BLU-667, XAV-939, Staurosporine, Telatinib, and entosplenitib, whereas decreased PAPSS2 expression was linked to decreased drug sensitivity of cancer cells to EMD-534085, Tamoxifen, ARQ-621, Pipamperone, and GNE-617.